IFNG and cancer: In patients with cancer, proinflammatory cytokines such as interleukin (IL)-1, IL-6, tumor necrosis factor alpha (TNF-α), interferon-alpha (IFN-α), and interferon-gamma (IFN-γ) are released by the tumor or the host’s immune system in reaction to the tumor [52].